A twist tale of cancer metastasis and tumor angiogenesis

Histology and Histopathology

Volumn 30, Issue 11, 2015, Pages 1283-1294

  Tseng, Jen Chieh ^a,b   Chen, Hsiao Fan ^b   Wu, Kou Juey ^b  

^a PERKINELMER INC   (United States)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Cancer stem cell; EMT; Twist1

Indexed keywords

NUCLEAR PROTEIN; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN, HUMAN;

ACROCEPHALOSYNDACTYLY; ANIMAL; CANCER STEM CELL; CELL MOTION; CELL TRANSDIFFERENTIATION; ENDOTHELIUM CELL; GENETICS; HUMAN; METABOLISM; METASTASIS; MORPHOGENESIS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; VASCULARIZATION;

ACROCEPHALOSYNDACTYLIA; ANIMALS; CELL MOVEMENT; CELL TRANSDIFFERENTIATION; ENDOTHELIAL CELLS; HUMANS; MORPHOGENESIS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PHENOTYPE; SIGNAL TRANSDUCTION; TWIST TRANSCRIPTION FACTOR;

EID: 84943741045     PISSN: 02133911     EISSN: 16995848     Source Type: Journal    
DOI: 10.14670/HH-11-638     Document Type: Review

References (138)

1. Ansieau S., Bastid J., Doreau A., Morel A.P., Bouchet B.P., Thomas C., Fauvet F., Puisieux I., Doglioni C., Piccinin S., Maestro R., Voeltzel T., Selmi A., Valsesia-Wittmann S., Caron de Fromentel C. and Puisieux A. (2008). Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14, 79-89.
2. Ashton R.S., Peltier J., Fasano C.A., O'Neill A., Leonard J., Temple S., Schaffer D.V. and Kane R.S. (2007). High-throughput screening of gene function in stem cells using clonal microarrays. Stem Cells 25, 2928-2935.
3. Battula V.L., Evans K.W., Hollier B.G., Shi Y., Marini F.C., Ayyanan A., Wang R.Y., Brisken C., Guerra R., Andreeff M. and Mani S.A. (2010). Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells 28, 1435-1445.
4. Bialek P., Kern B., Yang X., Schrock M., Sosic D., Hong N., Wu H., Yu K., Ornitz D.M., Olson E.N., Justice M.J. and Karsenty G. (2004). A twist code determines the onset of osteoblast differentiation. Dev. Cell 6, 423-435.
5. Bourgeois P., Bolcato-Bellemin A.L., Danse J.M., Bloch-Zupan A., Yoshiba K., Stoetzel C. and Perrin-Schmitt F. (1998). The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre- Chotzen syndrome. Hum. Mol. Genet. 7, 945-957.
6. Bracken A.P., Kleine-Kohlbrecher D., Dietrich N., Pasini D., Gargiulo G., Beekman C., Theilgaard-Monch K., Minucci S., Porse B.T., Marine J.C., Hansen K.H. and Helin K. (2007). The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 21, 525-530.
7. Bridges E., Oon C.E. and Harris A. (2011). Notch regulation of tumor angiogenesis. Future Oncol. 7, 569-588.
8. Bruggeman S.W., Valk-Lingbeek M.E., van der Stoop P.P., Jacobs J.J., Kieboom K., Tanger E., Hulsman D., Leung C., Arsenijevic Y., Marino S. and van Lohuizen M. (2005). Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1- deficient mice. Genes Dev. 19, 1438-1443.
9. Buszczak M. and Spradling A.C. (2006). Searching chromatin for stem cell identity. Cell 125, 233-236.
10. Canfield A.E., Sutton A.B., Hoyland J.A. and Schor A.M. (1996). Association of thrombospondin-1 with osteogenic differentiation of retinal pericytes in vitro. J. Cell Sci. 109 (2), 343-353.
11. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F. and Nieto M.A. (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell. Biol. 2, 76-83.
12. Cao Q., Yu J., Dhanasekaran S.M., Kim J.H., Mani R.S., Tomlins S.A., Mehra R., Laxman B., Cao X., Yu J., Kleer C.G., Varambally S. and Chinnaiyan A.M. (2008). Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27, 7274-7284.
13. Carmeliet P. and Jain R.K. (2000). Angiogenesis in cancer and other diseases. Nature 407, 249-257.
14. Castanon I. and Baylies M.K. (2002). A Twist in fate: evolutionary comparison of Twist structure and function. Gene 287, 11-22.
15. Castanon I., Von Stetina S., Kass J. and Baylies M.K. (2001). Dimerization partners determine the activity of the Twist bHLH protein during Drosophila mesoderm development. Development 128, 3145-3159.
16. Chen Z.F. and Behringer R.R. (1995). Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 9, 686-699.
17. Chen H.F., Huang C.H., Liu C.J., Hung J.J., Hsu C.C., Teng S.C. and Wu K.J. (2014). Twist1 induces endothelial differentiation of tumour cells through the Jagged1-KLF4 axis. Nat. Commun. 5, 4697.
18. Cheng G.Z., Chan J., Wang Q., Zhang W., Sun C.D. and Wang L.H. (2007). Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res. 67, 1979-1987.
19. Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., Mareel M., Huylebroeck D. and van Roy F. (2001). The two-handed E box binding zinc finger protein SIP1 downregulates Ecadherin and induces invasion. Mol. Cell 7, 1267-1278.
20. Conejo-Garcia J.R., Buckanovich R.J., Benencia F., Courreges M.C., Rubin S.C., Carroll R.G. and Coukos G. (2005). Vascular leukocytes contribute to tumor vascularization. Blood 105, 679-681.
21. Connerney J., Andreeva V., Leshem Y., Muentener C., Mercado M.A. and Spicer D.B. (2006). Twist1 dimer selection regulates cranial suture patterning and fusion. Dev. Dyn. 235, 1345-1357.
22. Connerney J., Andreeva V., Leshem Y., Mercado M.A., Dowell K., Yang X., Lindner V., Friesel R.E. and Spicer D.B. (2008). Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev. Biol. 318, 323-334.
23. Creighton C.J., Li X., Landis M., Dixon J.M., Neumeister V.M., Sjolund A., Rimm D.L., Wong H., Rodriguez A., Herschkowitz J.I., Fan C., Zhang X., He X., Pavlick A., Gutierrez M.C., Renshaw L., Larionov A.A., Faratian D., Hilsenbeck S.G., Perou C.M., Lewis M.T., Rosen J.M. and Chang J.C. (2009). Residual breast cancers after conventional therapy display mesenchymal as well as tumorinitiating features. Proc. Natl. Acad. Sci. USA 106, 13820-13825.
24. Creighton C.J., Chang J.C. and Rosen J.M. (2010). Epithelialmesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J. Mammary Gland. Biol. Neoplasia 15, 253-260.
25. Czermin B., Melfi R., McCabe D., Seitz V., Imhof A. and Pirrotta V. (2002). Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell 111, 185-196.
26. De Palma M., Venneri M.A., Galli R., Sergi Sergi L., Politi L.S., Sampaolesi M. and Naldini L. (2005). Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211-226.
27. Dhawan S., Tschen S.I. and Bhushan A. (2009). Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev. 23, 906-911.
28. Dufraine J., Funahashi Y. and Kitajewski J. (2008). Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene 27, 5132-5137.
29. el Ghouzzi V., Le Merrer M., Perrin-Schmitt F., Lajeunie E., Benit P., Renier D., Bourgeois P., Bolcato-Bellemin A.L., Munnich A. and Bonaventure J. (1997). Mutations of the TWIST gene in the Saethre- Chotzen syndrome. Nat. Genet. 15, 42-46.
30. Fasano C.A., Phoenix T.N., Kokovay E., Lowry N., Elkabetz Y., Dimos J.T., Lemischka I.R., Studer L. and Temple S. (2009). Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain. Genes Dev. 23, 561-574.
31. Feng M.Y., Wang K., Song H.T., Yu H.W., Qin Y., Shi Q.T. and Geng J.S. (2009). Metastasis-induction and apoptosis-protection by TWIST in gastric cancer cells. Clin. Exp. Metastasis 26, 1013-1023.
32. Firulli A.B. and Conway S.J. (2008). Phosphoregulation of Twist1 provides a mechanism of cell fate control. Curr. Med. Chem. 15, 2641-2647.
33. Fu J., Qin L., He T., Qin J., Hong J., Wong J., Liao L. and Xu J. (2011). The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res. 21, 275-289.
34. Furlong E.E., Andersen E.C., Null B., White K.P. and Scott M.P. (2001). Patterns of gene expression during Drosophila mesoderm development. Science 293, 1629-1633.
35. Fuxe J., Vincent T. and Garcia de Herreros A. (2010). Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 9, 2363-2374.
36. Gil J. and Peters G. (2006). Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7, 667-677.
37. Gil J., Bernard D. and Peters G. (2005). Role of polycomb group proteins in stem cell self-renewal and cancer. DNA Cell Biol. 24, 117-125.
38. Gitelman I. (2007). Evolution of the vertebrate twist family and synfunctionalization: a mechanism for differential gene loss through merging of expression domains. Mol. Biol. Evol. 24, 1912-1925.
39. Grooteclaes M.L. and Frisch S.M. (2000). Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19, 3823-3828.
40. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Jung S., Chimenti S., Landsman L., Abramovitch R. and Keshet E. (2006). VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124, 175-189.
41. Gupta P.B., Chaffer C.L. and Weinberg R.A. (2009). Cancer stem cells: mirage or reality? Nat. Med. 15, 1010-1012.
42. Hajra K.M., Chen D.Y. and Fearon E.R. (2002). The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 62, 1613-1618.
43. Hamamori Y., Wu H.Y., Sartorelli V. and Kedes L. (1997). The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist. Mol. Cell. Biol. 17, 6563-6573.
44. Hamamori Y., Sartorelli V., Ogryzko V., Puri P.L., Wu H.Y., Wang J.Y., Nakatani Y. and Kedes L. (1999). Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96, 405-413.
45. Hanahan D. and Weinberg R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
46. Hayashi M., Nimura K., Kashiwagi K., Harada T., Takaoka K., Kato H., Tamai K. and Kaneda Y. (2007). Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling. J. Cell Sci. 120, 1350-1357.
47. High F.A. and Epstein J.A. (2008). The multifaceted role of Notch in cardiac development and disease. Nat. Rev. Genet. 9, 49-61.
48. Hollier B.G., Evans K. and Mani S.A. (2009). The epithelial-tomesenchymal transition and cancer stem cells: a coalition against cancer therapies. J. Mammary Gland. Biol. Neoplasia 14, 29-43.
49. Howard T.D., Paznekas W.A., Green E.D., Chiang L.C., Ma N., Ortiz de Luna R.I., Garcia Delgado C., Gonzalez-Ramos M., Kline A.D. and Jabs E.W. (1997). Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat. Genet. 15, 36-41.
50. Iwama A., Oguro H., Negishi M., Kato Y., Morita Y., Tsukui H., Ema H., Kamijo T., Katoh-Fukui Y., Koseki H., van Lohuizen M. and Nakauchi H. (2004). Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 21, 843-851.
51. Jacobs J.J., Kieboom K., Marino S., DePinho R.A. and van Lohuizen M. (1999a). The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168.
52. Jacobs J.J., Scheijen B., Voncken J.W., Kieboom K., Berns A. and van Lohuizen M. (1999b). Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13, 2678-2690.
53. Jan Y.N. and Jan L.Y. (1993). HLH proteins, fly neurogenesis, and vertebrate myogenesis. Cell 75, 827-830.
54. Kalluri R. and Weinberg R.A. (2009). The basics of epithelialmesenchymal transition. J. Clin. Invest. 119, 1420-1428.
55. Keith B. and Simon M.C. (2007). Hypoxia-inducible factors, stem cells, and cancer. Cell 129, 465-472.
56. Kong D., Banerjee S., Ahmad A., Li Y., Wang Z., Sethi S. and Sarkar F.H. (2010). Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5, e12445.
57. Konuma T., Oguro H. and Iwama A. (2010). Role of the polycomb group proteins in hematopoietic stem cells. Dev. Growth Differ. 52, 505-516.
58. Kopp H.G., Ramos C.A. and Rafii S. (2006). Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr. Opin. Hematol. 13, 175-181.
59. Krebs I., Weis I., Hudler M., Rommens J.M., Roth H., Scherer S.W., Tsui L.C., Fuchtbauer E.M., Grzeschik K.H., Tsuji K. and Kunz J. (1997). Translocation breakpoint maps 5 kb 3' from TWIST in a patient affected with Saethre-Chotzen syndrome. Hum. Mol. Genet. 6, 1079-1086.
60. Kwok W.K., Ling M.T., Lee T.W., Lau T.C., Zhou C., Zhang X., Chua C.W., Chan K.W., Chan F.L., Glackin C., Wong Y.C. and Wang X. (2005). Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 65, 5153-5162.
61. Le Bras A., Vijayaraj P. and Oettgen P. (2010). Molecular mechanisms of endothelial differentiation. Vasc. Med. 15, 321-331.
62. Lee T.K., Poon R.T., Yuen A.P., Ling M.T., Kwok W.K., Wang X.H., Wong Y.C., Guan X.Y., Man K., Chau K.L. and Fan S.T. (2006). Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin. Cancer Res. 12, 5369-5376.
63. Lee J., Kanatsu-Shinohara M., Morimoto H., Kazuki Y., Takashima S., Oshimura M., Toyokuni S. and Shinohara T. (2009). Genetic reconstruction of mouse spermatogonial stem cell self-renewal in vitro by Ras-cyclin D2 activation. Cell Stem Cell 5, 76-86.
64. Lessard J. and Sauvageau G. (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-260.
65. Li Q.Q., Xu J.D., Wang W.J., Cao X.X., Chen Q., Tang F., Chen Z.Q., Liu X.P. and Xu Z.D. (2009). Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Clin. Cancer Res. 15, 2657-2665.
66. Lin E.Y., Nguyen A.V., Russell R.G. and Pollard J.W. (2001). Colonystimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-740.
67. Lu J., Ye X., Fan F., Xia L., Bhattacharya R., Bellister S., Tozzi F., Sceusi E., Zhou Y., Tachibana I., Maru D.M., Hawke D.H., Rak J., Mani S.A., Zweidler-McKay P. and Ellis L.M. (2013). Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1. Cancer Cell 23, 171-185.
68. Lukacs R.U., Memarzadeh S., Wu H. and Witte O.N. (2010). Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell 7, 682-693.
69. Luo G.Q., Li J.H., Wen J.F., Zhou Y.H., Hu Y.B. and Zhou J.H. (2008). Effect and mechanism of the Twist gene on invasion and metastasis of gastric carcinoma cells. World J. Gastroenterol. 14, 2487-2493.
70. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N.R., Crystal R.G., Moore M.A., Hajjar K.A., Manova K., Benezra R. and Rafii S. (2001). Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7, 1194-1201.
71. Maestro R., Dei Tos A.P., Hamamori Y., Krasnokutsky S., Sartorelli V., Kedes L., Doglioni C., Beach D.H. and Hannon G.J. (1999). Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13, 2207-2217.
72. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J. and Weinberg R.A. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715.
73. Massari M.E. and Murre C. (2000). Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20, 429-440.
74. Min J., Zhang Y. and Xu R.M. (2003). Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27. Genes Dev 17, 1823-1828.
75. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F. and Morrison S.J. (2003). Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425, 962-967.
76. Molofsky A.V., He S., Bydon M., Morrison S.J. and Pardal R. (2005). Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 19, 1432-1437.
77. Morel A.P., Lievre M., Thomas C., Hinkal G., Ansieau S. and Puisieux A. (2008). Generation of breast cancer stem cells through epithelialmesenchymal transition. PLoS One 3, e2888.
78. Muller J., Hart C.M., Francis N.J., Vargas M.L., Sengupta A., Wild B., Miller E.L., O'Connor M.B., Kingston R.E. and Simon J.A. (2002). Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell 111, 197-208.
79. Murre C., McCaw P.S., Vaessin H., Caudy M., Jan L.Y., Jan Y.N., Cabrera C.V., Buskin J.N., Hauschka S.D., Lassar A.B., Weintraub H. and Blatimore D. (1989). Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58, 537-544.
80. Nozawa H., Chiu C. and Hanahan D. (2006). Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad Sci. USA 103, 12493-12498.
81. O'Brien C.A., Kreso A. and Jamieson C.H. (2010). Cancer stem cells and self-renewal. Clin. Cancer Res. 16, 3113-3120.
82. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J. and Clarke M.F. (2003). Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302-305.
83. Park I.K., Morrison S.J. and Clarke M.F. (2004). Bmi1, stem cells, and senescence regulation. J. Clin. Invest. 113, 175-179.
84. Pereira C.F., Piccolo F.M., Tsubouchi T., Sauer S., Ryan N.K., Bruno L., Landeira D., Santos J., Banito A., Gil J., Koseki H., Merkenschlager M. and Fisher A.G. (2010). ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency. Cell Stem Cell 6, 547-556.
85. Perez-Moreno M.A., Locascio A., Rodrigo I., Dhondt G., Portillo F., Nieto M.A. and Cano A. (2001). A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J. Biol. Chem. 276, 27424-27431.
86. Pezzolo A., Parodi F., Corrias M.V., Cinti R., Gambini C. and Pistoia V. (2007). Tumor origin of endothelial cells in human neuroblastoma. J. Clin. Oncol. 25, 376-383.
87. Pietersen A.M., Evers B., Prasad A.A., Tanger E., Cornelissen-Steijger P., Jonkers J. and van Lohuizen M. (2008). Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr. Biol. 18, 1094-1099.
88. Pollard J.W. (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78.
89. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F. and Ailles L.E. (2007). Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 104, 973-978.
90. Puisieux A., Valsesia-Wittmann S. and Ansieau S. (2006). A twist for survival and cancer progression. Br. J. Cancer 94, 13-17.
91. Rajasekhar V.K. and Begemann M. (2007). Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective. Stem Cells 25, 2498-2510.
92. Reardon W. and Winter R.M. (1994). Saethre-Chotzen syndrome. J. Med. Genet. 31, 393-396.
93. Reya T., Morrison S.J., Clarke M.F. and Weissman I.L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
94. Ricci-Vitiani L., Pallini R., Biffoni M., Todaro M., Invernici G., Cenci T., Maira G., Parati E.A., Stassi G., Larocca L.M. and De Maria R. (2010). Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468, 824-828.
95. Rice D.P., Aberg T., Chan Y., Tang Z., Kettunen P.J., Pakarinen L., Maxson R.E. and Thesleff I. (2000). Integration of FGF and TWIST in calvarial bone and suture development. Development 127, 1845-1855.
96. Risau W. and Flamme I. (1995). Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11, 73-91.
97. Sangiorgi E. and Capecchi M.R. (2008). Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 40, 915-920.
98. Sangiorgi E. and Capecchi M.R. (2009). Bmi1 lineage tracing identifies a self-renewing pancreatic acinar cell subpopulation capable of maintaining pancreatic organ homeostasis. Proc. Natl. Acad. Sci. USA 106, 7101-7106.
99. Sasaki K., Natsugoe S., Ishigami S., Matsumoto M., Okumura H., Setoyama T., Uchikado Y., Kita Y., Tamotsu K., Sakamoto A., Owaki T. and Aikou T. (2009). Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res. 28, 158.
100. Satoh K., Hamada S., Kimura K., Kanno A., Hirota M., Umino J., Fujibuchi W., Masamune A., Tanaka N., Miura K., Egawa S., Motoi F., Unno M., Vonderhaar B.K. and Shimosegawa T. (2008). Upregulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells. Am. J. Pathol. 172, 926-939.
101. Simpson P. (1983). Maternal-zygotic gene interactions during formation of the dorsoventral pattern in drosophila embryos. Genetics 105, 615-632.
102. Singh S. and Gramolini A.O. (2009). Characterization of sequences in human TWIST required for nuclear localization. BMC Cell Biol. 10, 47.
103. Soda Y., Marumoto T., Friedmann-Morvinski D., Soda M., Liu F., Michiue H., Pastorino S., Yang M., Hoffman R.M., Kesari S. and Verma I.M. (2011). Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc. Natl. Acad. Sci. USA 108, 4274-4280.
104. Song S., Ewald A.J., Stallcup W., Werb Z. and Bergers G. (2005). PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat. Cell Biol. 7, 870-879.
105. Soo K., O'Rourke M.P., Khoo P.L., Steiner K.A., Wong N., Behringer R.R. and Tam P.P. (2002). Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo. Dev. Biol. 247, 251-270.
106. Sparmann A. and van Lohuizen M. (2006). Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 6, 846-856.
107. Spicer D.B., Rhee J., Cheung W.L. and Lassar A.B. (1996). Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science 272, 1476-1480.
108. Streubel B., Chott A., Huber D., Exner M., Jager U., Wagner O. and Schwarzinger I. (2004). Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N. Engl. J. Med. 351, 250-259.
109. Suzuki T., Aizawa K., Matsumura T. and Nagai R. (2005). Vascular implications of the Kruppel-like family of transcription factors. Arterioscler. Thromb. Vasc. Biol. 25, 1135-1141.
110. Teo A.K., Arnold S.J., Trotter M.W., Brown S., Ang L.T., Chng Z., Robertson E.J., Dunn N.R. and Vallier L. (2011). Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev. 25, 238-250.
111. Thiery J.P., Acloque H., Huang R.Y. and Nieto M.A. (2009). Epithelialmesenchymal transitions in development and disease. Cell 139, 871-890.
112. Thisse B., el Messal M. and Perrin-Schmitt F. (1987). The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res. 15, 3439-3453.
113. Thisse B., Stoetzel C., Gorostiza-Thisse C. and Perrin-Schmitt F. (1988). Sequence of the twist gene and nuclear localization of its protein in endomesodermal cells of early Drosophila embryos. EMBO J. 7, 2175-2183.
114. Valk-Lingbeek M.E., Bruggeman S.W. and van Lohuizen M. (2004). Stem cells and cancer; the polycomb connection. Cell 118, 409-418.
115. Valsesia-Wittmann S., Magdeleine M., Dupasquier S., Garin E., Jallas A.C., Combaret V., Krause A., Leissner P. and Puisieux A. (2004). Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 6, 625-630.
116. Vesuna F., Lisok A., Kimble B. and Raman V. (2009). Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 11, 1318-1328.
117. Wallerand H., Robert G., Pasticier G., Ravaud A., Ballanger P., Reiter R.E. and Ferriere J.M. (2010). The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers. Urol. Oncol. 28, 473-479.
118. Wang R., Chadalavada K., Wilshire J., Kowalik U., Hovinga K.E., Geber A., Fligelman B., Leversha M., Brennan C. and Tabar V. (2010). Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468, 829-833.
119. Weis S.M. and Cheresh D.A. (2011). Tumor angiogenesis: molecular pathways and therapeutic targets. Nat. Med. 17, 1359-1370.
120. Wu M.Z., Tsai Y.P., Yang M.H., Huang C.H., Chang S.Y., Chang C.C., Teng S.C. and Wu K.J. (2011). Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition. Mol. Cell 43, 811-822.
121. Wu C.Y., Tsai Y.P., Wu M.Z., Teng S.C. and Wu K.J. (2012). Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends Genet. 28, 454-463.
122. Xue Y., Gao X., Lindsell C.E., Norton C.R., Chang B., Hicks C., Gendron-Maguire M., Rand E.B., Weinmaster G. and Gridley T. (1999). Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 8, 723-730.
123. Yamanaka S. and Blau H.M. (2010). Nuclear reprogramming to a pluripotent state by three approaches. Nature 465, 704-712.
124. Yang J. and Weinberg R.A. (2008). Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818-829.
125. Yang M.H. and Wu K.J. (2008). TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle 7, 2090-2096.
126. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A. and Weinberg R.A. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939.
127. Yang J., Mani S.A. and Weinberg R.A. (2006). Exploring a new twist on tumor metastasis. Cancer Res. 66, 4549-4552.
128. Yang M.H., Wu M.Z., Chiou S.H., Chen P.M., Chang S.Y., Liu C.J., Teng S.C. and Wu K.J. (2008). Direct regulation of TWIST by HIF- 1alpha promotes metastasis. Nat. Cel.l Biol. 10, 295-305.
129. Yang D.H., Yoon J.Y., Lee S.H., Bryja V., Andersson E.R., Arenas E., Kwon Y.G. and Choi K.Y. (2009a). Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/beta-catenin and protein kinase Calpha. Circ. Res. 104, 372-379.
130. Yang M.H., Chen C.L., Chau G.Y., Chiou S.H., Su C.W., Chou T.Y., Peng W.L. and Wu J.C. (2009b). Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50, 1464-1474.
131. Yang M.H., Hsu D.S., Wang H.W., Wang H.J., Lan H.Y., Yang W.H., Huang C.H., Kao S.Y., Tzeng C.H., Tai S.K., Chang S.Y., Lee O.K. and Wu K.J. (2010). Bmi1 is essential in Twist1-induced epithelialmesenchymal transition. Nat. Cell Biol. 12, 982-992.
132. Yeh J.R., Zhang X. and Nagano M.C. (2011). Wnt5a is a cell-extrinsic factor that supports self-renewal of mouse spermatogonial stem cells. J. Cell Sci. 124, 2357-2366.
133. Yen H.Y., Ting M.C. and Maxson R.E. (2010). Jagged1 functions downstream of Twist1 in the specification of the coronal suture and the formation of a boundary between osteogenic and nonosteogenic cells. Dev. Biol. 347, 258-270.
134. Yet S.F., McA'Nulty M.M., Folta S.C., Yen H.W., Yoshizumi M., Hsieh C.M., Layne M.D., Chin M.T., Wang H., Perrella M.A., Jain M.K. and Lee M.E. (1998). Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J. Biol. Chem. 273, 1026-1031.
135. Yuen H.F., Chan Y.P., Wong M.L., Kwok W.K., Chan K.K., Lee P.Y., Srivastava G., Law S.Y., Wong Y.C., Wang X. and Chan K.W. (2007a). Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis. J. Clin. Pathol. 60, 510-514.
136. Yuen H.F., Chua C.W., Chan Y.P., Wong Y.C., Wang X. and Chan K.W. (2007b). Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer. Histopathology 50, 648-658.
137. Zeng Q., Li S., Chepeha D.B., Giordano T.J., Li J., Zhang H., Polverini P.J., Nor J., Kitajewski J. and Wang C.Y. (2005). Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8, 13-23.
138. Zhang Z., Xie D., Li X., Wong Y.C., Xin D., Guan X.Y., Chua C.W., Leung S.C., Na Y. and Wang X. (2007). Significance of TWIST expression and its association with E-cadherin in bladder cancer. Hum. Pathol. 38, 598-606.